| RS2521404010 |
HMGCL
|
Health Risk |
Likely pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Ovarian serous cystadenocarcinoma |
| RS2521405619 |
HMGCL
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2521409119 |
SLC9A6
|
Health Risk |
Pathogenic |
— |
| RS2521410230 |
PLS3
|
Health Risk |
Pathogenic |
— |
| RS2521410518 |
PLS3
|
Health Risk |
Pathogenic |
— |
| RS2521414161 |
STAG2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2521414626 |
PLS3
|
Health Risk |
Pathogenic |
— |
| RS2521419194 |
HMGCL
|
Health Risk |
Likely pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2521424016 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521424312 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521425675 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS2521432169 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2521440674 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2521440743 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2521440800 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2521441229 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2521441733 |
HMGCL
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2521446197 |
HCFC1
|
Health Risk |
Likely pathogenic |
Methylmalonic acidemia with homocystinuria, type cblX |
| RS2521450288 |
PUM1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2521451788 |
FMR1
|
Health Risk |
Likely pathogenic |
Fragile X syndrome, Fragile X syndrome |
| RS2521452743 |
PLS3
|
Health Risk |
Pathogenic |
— |
| RS2521452825 |
PLS3
|
Health Risk |
Pathogenic |
— |
| RS2521452967 |
PLS3
|
Health Risk |
Pathogenic |
Bone mineral density quantitative trait locus 18, Bone mineral density quantitative trait locus 18 |
| RS2521453615 |
PLS3
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS2521455305 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2521455405 |
HMGCL
|
Health Risk |
Likely pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2521455525 |
HMGCL
|
Health Risk |
Likely pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2521455723 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2521458985 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2521459845 |
SLC9A6
|
Health Risk |
Pathogenic |
Christianson syndrome, Christianson syndrome |
| RS2521468886 |
KDM6A
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2521471111 |
PLS3
|
Health Risk |
Likely pathogenic |
Hernia, anterior diaphragmatic |
| RS2521471675 |
PLS3
|
Health Risk |
Pathogenic |
— |
| RS2521475979 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2521479452 |
FMR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fragile X syndrome, Fragile X syndrome |
| RS2521479850 |
FMR1
|
Health Risk |
Pathogenic |
Fragile X syndrome, Fragile X syndrome |
| RS2521504046 |
FMR1
|
Health Risk |
Likely pathogenic |
Fragile X-associated tremor/ataxia syndrome, Fragile X-associated tremor/ataxia syndrome |
| RS2521505359 |
HMGCL
|
Health Risk |
Likely pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2521510445 |
UPF3B
|
Health Risk |
Pathogenic |
— |
| RS2521511100 |
UPF3B
|
Health Risk |
Pathogenic |
— |
| RS2521518413 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2521519226 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2521521060 |
PLS3
|
Health Risk |
Pathogenic |
— |
| RS2521522053 |
PLS3
|
Health Risk |
Pathogenic |
— |
| RS2521522129 |
VPS13D
|
Health Risk |
Pathogenic |
— |
| RS2521522247 |
PLS3
|
Health Risk |
Pathogenic |
— |
| RS2521526324 |
UPF3B
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability 14, Syndromic X-linked intellectual disability 14 |
| RS2521534355 |
PLS3
|
Health Risk |
Likely pathogenic |
X-linked osteoporosis with fractures, X-linked osteoporosis with fractures |
| RS2521537710 |
VPS13D
|
Health Risk |
Pathogenic |
Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome, Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome |
| RS2521545000 |
UPF3B
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability 14, Syndromic X-linked intellectual disability 14 |
| RS2521547128 |
PLS3
|
Health Risk |
Likely pathogenic |
Hernia, anterior diaphragmatic |
| RS2521554733 |
HCFC1
|
Health Risk |
Conflicting classifications of pathogenicity |
HCFC1-related disorder, Methylmalonic acidemia with homocystinuria |
| RS2521559588 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2521564145 |
PUM1
|
Health Risk |
Likely pathogenic |
PUM1-related disorder, PUM1-related disorder |
| RS2521574129 |
UPF3B
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability 14, Syndromic X-linked intellectual disability 14 |
| RS2521576667 |
UPF3B
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability 14, Syndromic X-linked intellectual disability 14 |
| RS2521577196 |
UPF3B
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability 14, Syndromic X-linked intellectual disability 14 |
| RS2521577214 |
UPF3B
|
Health Risk |
Pathogenic |
— |
| RS2521577389 |
HUWE1
|
Health Risk |
Likely pathogenic |
— |
| RS2521582948 |
UPF3B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2521596611 |
GABRA3
|
Health Risk |
Likely pathogenic |
Epilepsy, X-linked 2 |
| RS2521607268 |
RNF113A
|
Health Risk |
Likely pathogenic |
Trichothiodystrophy 5, nonphotosensitive |
| RS2521616187 |
FUCA1
|
Health Risk |
Likely pathogenic |
Fucosidosis, Fucosidosis |
| RS2521617594 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS2521618823 |
FUCA1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2521619739 |
DOCK11
|
Health Risk |
Pathogenic |
Autoinflammatory disease, multisystem |
| RS2521621423 |
GABRA3
|
Health Risk |
Pathogenic |
Epilepsy, X-linked 2 |
| RS2521622160 |
GPRASP2
|
Health Risk |
Likely pathogenic |
X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome, X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome |
| RS2521630196 |
CSTF2
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, X-linked 113 |
| RS2521634441 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS2521634585 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS2521635192 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS2521638529 |
LCK
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to LCK deficiency, Severe combined immunodeficiency due to LCK deficiency |
| RS2521643296 |
LCK
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to LCK deficiency, Severe combined immunodeficiency due to LCK deficiency |
| RS2521643351 |
KDM6A
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2521644688 |
LCK
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency disease, Severe combined immunodeficiency disease |
| RS2521645799 |
VPS13D
|
Health Risk |
Likely pathogenic |
Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome, Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome |
| RS2521649714 |
WNK3
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2521665871 |
PEX14
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, complementation group K |
| RS2521675340 |
HUWE1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked syndromic |
| RS2521697784 |
LCK
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to LCK deficiency, Severe combined immunodeficiency due to LCK deficiency |
| RS2521700282 |
IL2RG
|
Health Risk |
Likely pathogenic |
— |
| RS2521700334 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2521700357 |
IL2RG
|
Health Risk |
Pathogenic |
— |
| RS2521702130 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2521702222 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2521703323 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2521714324 |
PUM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Spinocerebellar ataxia 47 |
| RS2521715879 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2521730814 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS2521730880 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS2521731093 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS2521745475 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS2521745643 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS2521745894 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS2521748820 |
LCK
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to LCK deficiency, Severe combined immunodeficiency due to LCK deficiency |
| RS2521753491 |
SMARCA1
|
Health Risk |
Likely pathogenic |
Non-syndromic X-linked intellectual disability, Non-syndromic X-linked intellectual disability |
| RS2521759907 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS2521760199 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2521760820 |
FUCA1
|
Health Risk |
Likely pathogenic |
Fucosidosis, Fucosidosis |